Price to Earnings (P/E)
since 2005
Paying user area
Try for free
Stryker Corp. pages available for free this week:
- Analysis of Liquidity Ratios
- Common Stock Valuation Ratios
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Net Profit Margin since 2005
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Stryker Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Stryker Corp., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net earnings1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | = | ÷ | = | ÷ | |||||||
| Feb 11, 2021 | = | ÷ | = | ÷ | |||||||
| Feb 6, 2020 | = | ÷ | = | ÷ | |||||||
| Feb 7, 2019 | = | ÷ | = | ÷ | |||||||
| Feb 8, 2018 | = | ÷ | = | ÷ | |||||||
| Feb 9, 2017 | = | ÷ | = | ÷ | |||||||
| Feb 11, 2016 | = | ÷ | = | ÷ | |||||||
| Feb 12, 2015 | = | ÷ | = | ÷ | |||||||
| Feb 13, 2014 | = | ÷ | = | ÷ | |||||||
| Feb 27, 2013 | = | ÷ | = | ÷ | |||||||
| Feb 13, 2012 | = | ÷ | = | ÷ | |||||||
| Feb 18, 2011 | = | ÷ | = | ÷ | |||||||
| Feb 26, 2010 | = | ÷ | = | ÷ | |||||||
| Feb 20, 2009 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2008 | = | ÷ | = | ÷ | |||||||
| Feb 28, 2007 | = | ÷ | = | ÷ | |||||||
| Mar 7, 2006 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Stryker Corp. Annual Report.
The share price exhibits an overall upward trend from 2006 to 2022, increasing from $45.81 to $251.65. Notable fluctuations occur throughout this period. After a peak in 2008 at $66.04, there is a decline in 2009 to $40.03. Subsequently, the price recovers and shows consistent growth, reaching a significant high of $251.65 in 2022. This progression indicates investor confidence growth over the long term despite short-term volatility.
Earnings per share (EPS) demonstrate variability with periods of growth and decline. EPS increased steadily from $1.66 in 2006 to a peak of $3.53 in 2012, followed by a decrease to $2.66 in 2014 and a sharper drop to $1.36 in 2015. After 2015, EPS rose again, achieving a maximum of $9.53 in 2019, before decreasing to $4.25 in 2021 and increasing again to $5.28 in 2022. This pattern suggests some inconsistency in profitability or earnings quality, potentially due to operational or market factors impacting the company.
The price-to-earnings (P/E) ratio exhibits considerable volatility over the years. It started at 27.54 in 2006, peaked at 32.57 in 2007, and dropped significantly to 13.83 in 2009 during the period of lower share price and relatively stable EPS. P/E ratios showed spikes in 2010, 2014, and 2021 to 19.09, 31.08, and 57.72 respectively, reflecting fluctuations in investor valuation relative to earnings. Notably, the P/E ratio reached exceptionally high values in 2014 (68.67) and 2018 (54.36), which could indicate market expectations of future growth or possibly overvaluation during these times. Variations in the P/E ratio correspond with changes in EPS and share price, confirming shifting market sentiment.
Overall, the data suggests growth in market valuation, characterized by increasing share price over the long term. Earnings performance shows cyclical characteristics with intermittent declines and recoveries, while investor valuation as reflected by the P/E ratio is marked by significant fluctuation, indicating variable market expectations and sentiment toward future earnings growth.
Comparison to Competitors
Stryker Corp., P/E, long-term trends, comparison to competitors
| Stryker Corp. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | |||||||
| Feb 11, 2021 | |||||||
| Feb 6, 2020 | |||||||
| Feb 7, 2019 | |||||||
| Feb 8, 2018 | |||||||
| Feb 9, 2017 | |||||||
| Feb 11, 2016 | |||||||
| Feb 12, 2015 | |||||||
| Feb 13, 2014 | |||||||
| Feb 27, 2013 | |||||||
| Feb 13, 2012 | |||||||
| Feb 18, 2011 | |||||||
| Feb 26, 2010 | |||||||
| Feb 20, 2009 | |||||||
| Feb 28, 2008 | |||||||
| Feb 28, 2007 | |||||||
| Mar 7, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Stryker Corp., P/E, long-term trends, comparison to sector (health care equipment & services)
| Stryker Corp. | Health Care Equipment & Services | |
|---|---|---|
| Feb 11, 2022 | ||
| Feb 11, 2021 | ||
| Feb 6, 2020 | ||
| Feb 7, 2019 | ||
| Feb 8, 2018 | ||
| Feb 9, 2017 | ||
| Feb 11, 2016 | ||
| Feb 12, 2015 | ||
| Feb 13, 2014 | ||
| Feb 27, 2013 | ||
| Feb 13, 2012 | ||
| Feb 18, 2011 | ||
| Feb 26, 2010 | ||
| Feb 20, 2009 | ||
| Feb 28, 2008 | ||
| Feb 28, 2007 | ||
| Mar 7, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Stryker Corp., P/E, long-term trends, comparison to industry (health care)
| Stryker Corp. | Health Care | |
|---|---|---|
| Feb 11, 2022 | ||
| Feb 11, 2021 | ||
| Feb 6, 2020 | ||
| Feb 7, 2019 | ||
| Feb 8, 2018 | ||
| Feb 9, 2017 | ||
| Feb 11, 2016 | ||
| Feb 12, 2015 | ||
| Feb 13, 2014 | ||
| Feb 27, 2013 | ||
| Feb 13, 2012 | ||
| Feb 18, 2011 | ||
| Feb 26, 2010 | ||
| Feb 20, 2009 | ||
| Feb 28, 2008 | ||
| Feb 28, 2007 | ||
| Mar 7, 2006 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).